Partner Brent Babcock was quoted in, “Patent Awards Give Berkeley a Needed Gene-Edit Boost,” an article published by Bloomberg Law.
Excerpt: “The University of California, Berkeley, is on the board in the ongoing U.S. patent contest over CRISPR- Cas9 gene-editing technology, but it’s still behind and it’s not clear it can catch up.”
Read full article here >> (Subscription Required)